Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)
Authors
Keywords
-
Journal
ORAL ONCOLOGY
Volume 139, Issue -, Pages 106358
Publisher
Elsevier BV
Online
2023-03-03
DOI
10.1016/j.oraloncology.2023.106358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment
- (2022) Ari J. Rosenberg et al. BMC CANCER
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
- (2021) Gong Chen et al. Journal of Hematology & Oncology
- 1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
- (2021) M.G. Kris et al. ANNALS OF ONCOLOGY
- Next generation sequencing of cell free circulating tumor DNA in blood samples of recurrent and metastatic head and neck cancer patients
- (2020) Ashleigh Porter et al. Translational Cancer Research
- Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma
- (2020) Rachel Galot et al. ORAL ONCOLOGY
- Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs
- (2020) Yiling Meng et al. Biomarkers in Medicine
- The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
- (2020) Harper L Wilson et al. ONCOLOGIST
- Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
- (2020) Javier Fernández-Mateos et al. Scientific Reports
- Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
- (2020) M.J.M. Magbanua et al. ANNALS OF ONCOLOGY
- Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
- (2019) Bhishamjit S Chera et al. CLINICAL CANCER RESEARCH
- HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study
- (2019) Panagiota Economopoulou et al. PLoS One
- Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer
- (2019) Elena Elez et al. Molecular Oncology
- TP53Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response
- (2016) Ge Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
- (2015) Yuxuan Wang et al. Science Translational Medicine
- Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer
- (2011) D. Sano et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started